MLE4901 vs. Placebo for the Treatment of PCOS

Status Terminated

Clinical Trial Summary

This is a Phase 2b double-blind, randomized, parallel-group, placebo-controlled study of MLE4901 versus placebo in women with PCOS.

Clinical Trial Description

Following a Screening/Wash-out Period of up to 12 weeks, an 8-week Lead-in Period (starting with a progestin challenge) will be used to better characterize the study population. A Treatment Period of 28 weeks' duration will follow the Lead-in Period. Then, an 8-week Follow-up Period (i.e., no study drug) will be used to assess the durability of effects of MLE4901. The study duration will be approximately 48 weeks (11 months) per subject ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02865915
Study type	Interventional
Source	Millendo Therapeutics, Inc.
Contact
Status	Terminated
Phase	Phase 2
Start date	July 2016
Completion date	September 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06306417` - A Randomized Controlled Trial of Acupuncture for Insulin Resistance in Patients With Polycystic Ovary Syndrome	N/A
Completed	`NCT01927471` - Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome
Completed	`NCT01927432` - Ultrasound Characterization of Ovarian Follicle Dynamics in Women With Amenorrhea
Completed	`NCT00805207` - Sex Steroids, Sleep, and Metabolic Dysfunction in Women	N/A
Completed	`NCT01999686` - PCOS Treatment Using DLBS3233, Metformin, and Combination of Both	Phase 3
Completed	`NCT03414957` - Malay Women With PCOS and Their Association With Metabolic Syndrome
Recruiting	`NCT06143527` - Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS	Phase 1
Recruiting	`NCT05394142` - A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)	Phase 2
Completed	`NCT01233206` - Metformin in High Responder Polycystic Ovary Syndrome (PCOS) Patients Undergoing IVF Cycles	Phase 4
Not yet recruiting	`NCT05272657` - Low-Carb Versus Mediterranean Diet in PCOS	N/A
Completed	`NCT01733459` - Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)	Phase 3
Completed	`NCT04264832` - Body Fat Distribution and Its Associated Factors in Chinese Women With Polycystic Ovary Syndrome
Completed	`NCT03547453` - Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome
Completed	`NCT02429128` - 14 Weeks Exercise Training on Lean Women With and Without PCOS	N/A
Completed	`NCT01899001` - Mood and Nutrition Interventions in Polycystic Ovary Syndrome	N/A
Completed	`NCT03151005` - The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS	Phase 4
Completed	`NCT03792282` - Time-Restricted Feeding(TRF) on Overweight/Obese Women With Polycystic Ovarian Syndrome (PCOS)	N/A
Completed	`NCT04852510` - Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin	Phase 2/Phase 3
Recruiting	`NCT05200793` - Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome	Phase 4
Not yet recruiting	`NCT01720459` - Effects of Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients	N/A